Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FU5E
|
|||
| Former ID |
DNC004665
|
|||
| Drug Name |
S-34324
|
|||
| Synonyms |
CHEMBL90997; S-34324; SCHEMBL6949357; BDBM50131357; 4-(5-Fluoro-2-indanylmethyl)-2-imidazoline; L001645
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H15FN2
|
|||
| Canonical SMILES |
C1C(CC2=C1C=CC(=C2)F)CC3CN=CN3
|
|||
| InChI |
1S/C13H15FN2/c14-12-2-1-10-3-9(4-11(10)6-12)5-13-7-15-8-16-13/h1-2,6,8-9,13H,3-5,7H2,(H,15,16)
|
|||
| InChIKey |
HBMJQYDGBNSZMC-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking... J Med Chem. 2005 Mar 24;48(6):2054-71. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.